Actos Bladder Cancer Lawsuit Filed By Diabetes Patient
A California man has filed one of the first Actos bladder cancer lawsuits against Takeda Pharmaceuticals in the United States, alleging that the popular diabetes drug caused him to develop…
A California man has filed one of the first Actos bladder cancer lawsuits against Takeda Pharmaceuticals in the United States, alleging that the popular diabetes drug caused him to develop…
European medical officials are calling for new warnings about the risk of bladder cancer from Actos to be added to Takeda Pharmaceutical’s popular diabetes drug.
A new diabetes drug being developed by Bristol-Myers Squibb and AstraZeneca could be derailed by increased risks of bladder cancer and breast cancer.
A month after French regulators suspended sales of their popular diabetes drug due to concerns about an increased risk of bladder cancer, Takeda Pharmaceuticals has agreed to issue an Actos…
Canadian health officials are launching their own review of the possible risk of bladder cancer from Actos, after warnings were issued last week in the United States and several European…
Federal health regulators are warning that side effects of Actos, Takeda Pharmaceutical’s popular diabetes drug, may increase the risk of bladder cancer when it is taken for more than a…
After French and German drug regulators announced last week that they were suspending the diabetes drug Actos due to concerns about a potential risk of bladder cancer, other European countries…
French health authorities have suspended Actos sales, following data that provides further evidence that users of the diabetes drug may face an increased risk of bladder cancer.